JPMorgan Downgrades HCP (HCP) to Neutral
Tweet
Share
E-mail
Get Alerts HCP Hot Sheet
Price: $34.78 --0%
Rating Summary:
15 Buy, 20 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 20 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan analyst Anthony Paolone downgraded HCP (NYSE: HCP) from Overweight to Neutral with a price target of $28.00.
The analyst steps aside in part to his improved outlook for other REIT names. He does not believes the current relative valuation is standing out as well as it has previously and believes NT FFO growth is likely to be mute.
For an analyst ratings summary and ratings history on HCP click here. For more ratings news on HCP click here.
Shares of HCP closed at $25.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- McGraw Hill (MH) PT Raised to $15 at UBS
- UBS Reiterates Buy Rating on HF Sinclair (DINO)
Create E-mail Alert Related Categories
Analyst Comments, DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
